Search

Your search keyword '"Andersen, Peter"' showing total 8,201 results
Start Over Author "Andersen, Peter"

Refine your results

8,201 results on '"Andersen, Peter"'

2. The Miami Framework for ALS and related neurodegenerative disorders: an integrated view of phenotype and biology

Author

Benatar, Michael, Wuu, Joanne, Huey, Edward D., McMillan, Corey T., Petersen, Ronald C., Postuma, Ronald, McHutchison, Caroline, Dratch, Laynie, Arias, Jalayne J., Crawley, Anita, Houlden, Henry, McDermott, Michael P., Cai, Xueya, Thakur, Neil, Boxer, Adam, Rosen, Howard, Boeve, Bradley F., Dacks, Penny, Cosentino, Stephanie, Abrahams, Sharon, Shneider, Neil, Lingor, Paul, Shefner, Jeremy, Andersen, Peter M., Al-Chalabi, Ammar, and Turner, Martin R.

Published
2024
Full Text
View/download PDF

9. Publisher Correction: The Miami Framework for ALS and related neurodegenerative disorders: an integrated view of phenotype and biology

Author

Benatar, Michael, Wuu, Joanne, Huey, Edward D., McMillan, Corey T., Petersen, Ronald C., Postuma, Ronald, McHutchison, Caroline, Dratch, Laynie, Arias, Jalayne J., Crawley, Anita, Houlden, Henry, McDermott, Michael P., Cai, Xueya, Thakur, Neil, Boxer, Adam, Rosen, Howard, Boeve, Bradley F., Dacks, Penny, Cosentino, Stephanie, Abrahams, Sharon, Shneider, Neil, Lingor, Paul, Shefner, Jeremy, Andersen, Peter M., Al-Chalabi, Ammar, and Turner, Martin R.

Published
2024
Full Text
View/download PDF

11. Development of a Smartphone App for a Genetics Website: The Amyotrophic Lateral Sclerosis Online Genetics Database (ALSoD)

Author

Abel, Olubunmi, Shatunov, Aleksey, Jones, Ashley R, Andersen, Peter M, Powell, John F, and Al-Chalabi, Ammar

Subjects
Information technology, T58.5-58.64, Public aspects of medicine, RA1-1270
Abstract

BackgroundThe ALS Online Genetics Database (ALSoD) website holds mutation, geographical, and phenotype data on genes implicated in amyotrophic lateral sclerosis (ALS) and links to bioinformatics resources, publications, and tools for analysis. On average, there are 300 unique visits per day, suggesting a high demand from the research community. To enable wider access, we developed a mobile-friendly version of the website and a smartphone app. ObjectiveWe sought to compare data traffic before and after implementation of a mobile version of the website to assess utility. MethodsWe identified the most frequently viewed pages using Google Analytics and our in-house analytic monitoring. For these, we optimized the content layout of the screen, reduced image sizes, and summarized available information. We used the Microsoft .NET framework mobile detection property (HttpRequest.IsMobileDevice in the Request.Browser object in conjunction with HttpRequest.UserAgent), which returns a true value if the browser is a recognized mobile device. For app development, we used the Eclipse integrated development environment with Android plug-ins. We wrapped the mobile website version with the WebView object in Android. Simulators were downloaded to test and debug the applications. ResultsThe website automatically detects access from a mobile phone and redirects pages to fit the smaller screen. Because the amount of data stored on ALSoD is very large, the available information for display using smartphone access is deliberately restricted to improve usability. Visits to the website increased from 2231 to 2820, yielding a 26% increase from the pre-mobile to post-mobile period and an increase from 103 to 340 visits (230%) using mobile devices (including tablets). The smartphone app is currently available on BlackBerry and Android devices and will be available shortly on iOS as well. ConclusionsFurther development of the ALSoD website has allowed access through smartphones and tablets, either through the website or directly through a mobile app, making genetic data stored on the database readily accessible to researchers and patients across multiple devices.

Published
2013
Full Text
View/download PDF

15. An investigation of trachoma vaccine regimens by the chlamydia vaccine CTH522 administered with cationic liposomes in healthy adults (CHLM-02): a phase 1, double-blind trial

Author

Pollock, Katrina M, Borges, Álvaro H, Cheeseman, Hannah M, Rosenkrands, Ida, Schmidt, Kirstine L, Søndergaard, Rie E, Day, Suzanne, Evans, Abbey, McFarlane, Leon R, Joypooranachandran, Jennifer, Amini, Fahimah, Skallerup, Per, Dohn, Rebecca B, Jensen, Charlotte G, Olsen, Anja W, Bang, Peter, Cole, Tom, Schronce, Joanna, Lemm, Nana-Marie, Kristiansen, Max P, Andersen, Peter L, Dietrich, Jes, Shattock, Robin J, and Follmann, Frank

Published
2024
Full Text
View/download PDF

19. Safety and efficacy of arimoclomol in patients with early amyotrophic lateral sclerosis (ORARIALS-01): a randomised, double-blind, placebo-controlled, multicentre, phase 3 trial

Author

Granit, Volkan, Steele, Julie, Levy, Wendy, Paredes, Maria Elena, Hernandez, Jessica, Bilsker, Martin, Szacka, Katarzyna, Ronert, Adam, Jablońska, Dorota, Łuczak, Alina Zuzanna, Chaverri, Delia, Janse van Mantgem, Mark R, Bunte, Tommy M, Broere, Bianca, de Fockert, Arianne, Sanchez-Tejerina, Daniel, Landabaso, Carmen, Calvo, Andrea, Moglia, Cristina, Manera, Umberto, Canosa, Antonio, Vasta, Rosario, Salamone, Paolina, Fuda, Giuseppe, DeMarco, Giovanni, Casale, Federico, ME Forsberg, Karin, Winroth, Ivar, Almgren Stenberg, Erica, Holmgren, Monica, Amador, Maria del Mar, Lenglet, Timothee, Querin, Giorgia, Coudoin, Sylvie, Pavlakis, Pantelis, Holzberg, Shara, Sideri, Riccardo, Marinou, Kalliopi, Czarnecki, Maciej, Ługiewicz, Renata, Biel-Czarnecka, Marta, Boczkowska, Marcelina, Schotte, Caroline, Vynckier, Jan, Van Daele, Sien, Claeys, Thomas, Delmotte, Koen, Swinnen, Bart, Serrien, Anouk, D'Hondt, Ann, Lamaire, Nikita, Debien, Elisa, Jones, Sarah, Vachon, Chris, Grogan, James, Solorzano, Guillermo, Crowell, Allison, Rakocevic, Goran, Wagoner, Mary, Alma, Osmanovic, Flavia, Wiehler, Sonja, Körner, Olivia, Schreiber-Katz, Camilla, Wohnrade, Anastasia, Sarikidi, Carola, Kassebaum, Chantal, Fischer, Adamo, Ashley, Turcotte, Nicole, Duncan, Jessie, Turner, Ivone, Elman, Lauren, Massie, Rami, Berube, Maxime, Saunders, Natalie, Salmon, Kristiana, Foucher, Juliette, Agessandro, Abrahao, Shirley, Pham, Jahan, Mookshah, Phung, Liane, Statland, Jeffrey, Jawdat, Omar, Dimachkie, Mazen, Pasnoor, Mamatha, Farmakidis, Constantine, Heim, Andrew, Lillig, Katie, Lackey, Alyssa, Weber, Markus, Kurz, Martina, Levine, Todd, Benatar, Michael, Hansen, Thomas, Rom, Dror, Geist, Marie A, Blaettler, Thomas, Camu, William, Kuzma-Kozakiewicz, Magdalena, van den Berg, Leonard H, Morales, Raul Juntas, Chio, Adriano, Andersen, Peter M, Pradat, Pierre-Francois, Lange, Dale, Van Damme, Philip, Mora, Gabriele, Grudniak, Mariusz, Elliott, Matthew, Petri, Susanne, Olney, Nicholas, Ladha, Shafeeq, Goyal, Namita A, Meyer, Thomas, Hanna, Michael G, Quinn, Colin, Genge, Angela, Zinman, Lorne, Jabari, Duaa, Shoesmith, Christen, Ludolph, Albert C, Neuwirth, Christoph, Nations, Sharon, Shefner, Jeremy M, Turner, Martin R, Wuu, Joanne, Bennett, Richard, Dang, Hoang, and Sundgreen, Claus

Published
2024
Full Text
View/download PDF

21. Using liver stiffness to predict and monitor the risk of decompensation and mortality in patients with alcohol-related liver disease

Author

Thorhauge, Katrine Holtz, Semmler, Georg, Johansen, Stine, Lindvig, Katrine Prier, Kjærgaard, Maria, Hansen, Johanne Kragh, Torp, Nikolaj, Hansen, Camilla Dalby, Andersen, Peter, Hofer, Benedikt Silvester, Gu, Wenyi, Israelsen, Mads, Mandorfer, Mattias, Reiberger, Thomas, Trebicka, Jonel, Thiele, Maja, and Krag, Aleksander

Published
2024
Full Text
View/download PDF

23. Author Correction: Integrative genetic analysis illuminates ALS heritability and identifies risk genes

Author

Megat, Salim, Mora, Natalia, Sanogo, Jason, Roman, Olga, Catanese, Alberto, Alami, Najwa Ouali, Freischmidt, Axel, Mingaj, Xhuljana, De Calbiac, Hortense, Muratet, François, Dirrig-Grosch, Sylvie, Dieterle, Stéphane, Van Bakel, Nick, Müller, Kathrin, Sieverding, Kirsten, Weishaupt, Jochen, Andersen, Peter Munch, Weber, Markus, Neuwirth, Christoph, Margelisch, Markus, Sommacal, Andreas, Van Eijk, Kristel R., Veldink, Jan H., Lautrette, Géraldine, Couratier, Philippe, Camuzat, Agnès, Le Ber, Isabelle, Grassano, Maurizio, Chio, Adriano, Boeckers, Tobias, Ludolph, Albert C., Roselli, Francesco, Yilmazer-Hanke, Deniz, Millecamps, Stéphanie, Kabashi, Edor, Storkebaum, Erik, Sellier, Chantal, and Dupuis, Luc

Published
2023
Full Text
View/download PDF

25. Integrative genetic analysis illuminates ALS heritability and identifies risk genes

Author

Megat, Salim, Mora, Natalia, Sanogo, Jason, Roman, Olga, Catanese, Alberto, Alami, Najwa Ouali, Freischmidt, Axel, Mingaj, Xhuljana, De Calbiac, Hortense, Muratet, François, Dirrig-Grosch, Sylvie, Dieterle, Stéphane, Van Bakel, Nick, Müller, Kathrin, Sieverding, Kirsten, Weishaupt, Jochen, Andersen, Peter Munch, Weber, Markus, Neuwirth, Christoph, Margelisch, Markus, Sommacal, Andreas, Van Eijk, Kristel R., Veldink, Jan H., Lautrette, Géraldine, Couratier, Philippe, Camuzat, Agnès, Le Ber, Isabelle, Grassano, Maurizio, Chio, Adriano, Boeckers, Tobias, Ludolph, Albert C., Roselli, Francesco, Yilmazer-Hanke, Deniz, Millecamps, Stéphanie, Kabashi, Edor, Storkebaum, Erik, Sellier, Chantal, and Dupuis, Luc

Published
2023
Full Text
View/download PDF

26. Conserved transcription factors promote cell fate stability and restrict reprogramming potential in differentiated cells

Author

Missinato, Maria A., Murphy, Sean, Lynott, Michaela, Yu, Michael S., Kervadec, Anaïs, Chang, Yu-Ling, Kannan, Suraj, Loreti, Mafalda, Lee, Christopher, Amatya, Prashila, Tanaka, Hiroshi, Huang, Chun-Teng, Puri, Pier Lorenzo, Kwon, Chulan, Adams, Peter D., Qian, Li, Sacco, Alessandra, Andersen, Peter, and Colas, Alexandre R.

Published
2023
Full Text
View/download PDF

27. Preventing amyotrophic lateral sclerosis: insights from pre-symptomatic neurodegenerative diseases

Author

Benatar, Michael, Wuu, Joanne, McHutchison, Caroline, Postuma, Ronald B, Boeve, Bradley F, Petersen, Ronald, Ross, Christopher A, Rosen, Howard, Arias, Jalayne J, Fradette, Stephanie, McDermott, Michael P, Shefner, Jeremy, Stanislaw, Christine, Abrahams, Sharon, Cosentino, Stephanie, Andersen, Peter M, Finkel, Richard S, Granit, Volkan, Grignon, Anne-Laure, Rohrer, Jonathan D, McMillan, Corey T, Grossman, Murray, Al-Chalabi, Ammar, Turner, Martin R, Arias, Jalayne, Boeve, Bradley, Dave, Kuldip, Ferguson, Toby, Floeter, Mary-Kay, Rohrer, Jonathan, Gendron, Tania, Gubitz, Amelie, Kaufman, Petra, Le Ber, Isabelle, Lee, Suzee, Malaspina, Andrea, McMillan, Corey, Nicholson, Katie, Postuma, Ronald, Robinson, Richard, Ross, Christopher, Tatton, Nadine, Thakur, Neil, Turner, Martin, and Weishaupt, Jochen

Subjects
Biomedical and Clinical Sciences, Health Sciences, Psychology, Neurodegenerative, Dementia, Genetics, Alzheimer's Disease, Rare Diseases, Aging, Prevention, Brain Disorders, Neurosciences, Clinical Research, Alzheimer's Disease including Alzheimer's Disease Related Dementias (AD/ADRD), ALS, Acquired Cognitive Impairment, Biotechnology, Detection, screening and diagnosis, 2.1 Biological and endogenous factors, 4.1 Discovery and preclinical testing of markers and technologies, Aetiology, Neurological, Alzheimer Disease, Amyotrophic Lateral Sclerosis, Asymptomatic Diseases, Frontotemporal Dementia, Humans, Neurodegenerative Diseases, neurodegeneration, amyotrophic lateral sclerosis, pre-symptomatic, disease prevention, First International Pre-Symptomatic ALS Workshop, Medical and Health Sciences, Psychology and Cognitive Sciences, Neurology & Neurosurgery, Biomedical and clinical sciences, Health sciences
Abstract

Significant progress has been made in understanding the pre-symptomatic phase of amyotrophic lateral sclerosis. While much is still unknown, advances in other neurodegenerative diseases offer valuable insights. Indeed, it is increasingly clear that the well-recognized clinical syndromes of Alzheimer's disease, Parkinson's disease, Huntington's disease, spinal muscular atrophy and frontotemporal dementia are also each preceded by a pre-symptomatic or prodromal period of varying duration, during which the underlying disease process unfolds, with associated compensatory changes and loss of inherent system redundancy. Key insights from these diseases highlight opportunities for discovery in amyotrophic lateral sclerosis. The development of biomarkers reflecting amyloid and tau has led to a shift in defining Alzheimer's disease based on inferred underlying histopathology. Parkinson's disease is unique among neurodegenerative diseases in the number and diversity of non-genetic biomarkers of pre-symptomatic disease, most notably REM sleep behaviour disorder. Huntington's disease benefits from an ability to predict the likely timing of clinically manifest disease based on age and CAG-repeat length alongside reliable neuroimaging markers of atrophy. Spinal muscular atrophy clinical trials have highlighted the transformational value of early therapeutic intervention, and studies in frontotemporal dementia illustrate the differential role of biomarkers based on genotype. Similar advances in amyotrophic lateral sclerosis would transform our understanding of key events in pathogenesis, thereby dramatically accelerating progress towards disease prevention. Deciphering the biology of pre-symptomatic amyotrophic lateral sclerosis relies on a clear conceptual framework for defining the earliest stages of disease. Clinically manifest amyotrophic lateral sclerosis may emerge abruptly, especially among those who harbour genetic mutations associated with rapidly progressive amyotrophic lateral sclerosis. However, the disease may also evolve more gradually, revealing a prodromal period of mild motor impairment preceding phenoconversion to clinically manifest disease. Similarly, cognitive and behavioural impairment, when present, may emerge gradually, evolving through a prodromal period of mild cognitive impairment or mild behavioural impairment before progression to amyotrophic lateral sclerosis. Biomarkers are critically important to studying pre-symptomatic amyotrophic lateral sclerosis and essential to efforts to intervene therapeutically before clinically manifest disease emerges. The use of non-genetic biomarkers, however, presents challenges related to counselling, informed consent, communication of results and limited protections afforded by existing legislation. Experiences from pre-symptomatic genetic testing and counselling, and the legal protections against discrimination based on genetic data, may serve as a guide. Building on what we have learned-more broadly from other pre-symptomatic neurodegenerative diseases and specifically from amyotrophic lateral sclerosis gene mutation carriers-we present a road map to early intervention, and perhaps even disease prevention, for all forms of amyotrophic lateral sclerosis.

Published
2022

31. Infections increase the risk of decompensation and death in patients with early alcohol-related liver disease

Author

Anastasiadou, Ema, Arumugam, Manimozhian, Bork, Peer, Hansen, Torben, Presto, Jenny, Israelsen, Hans, Karsdal, Morten, Legido-Quigley, Cristina, Melberg, Hans Olav, Thiele, Maja, Trebicka, Jonel, Krag, Aleksander, Mann, Mathias, Matthijnssens, Jelle, Johansen, Stine, Langkjær, Simon, Rasmussen, Ditlev Nytoft, Israelsen, Mads, Torp, Nikolaj, Lindvig, Katrine, Kjærgaard, Maria, Hansen, Johanne Kragh, Hansen, Camilla Dalby, Thorhauge, Katrine, Andersen, Peter, Detlefsen, Sönke, Juel, Helene Bæk, and Justesen, Ulrik Stenz

Published
2024
Full Text
View/download PDF

33. Validation of the new nomenclature of steatotic liver disease in patients with a history of excessive alcohol intake: an analysis of data from a prospective cohort study

Author

Israelsen, Mads, Torp, Nikolaj, Johansen, Stine, Hansen, Camilla Dalby, Hansen, Emil Deleuran, Thorhauge, Katrine, Hansen, Johanne Kragh, Villesen, Ida, Bech, Katrine, Wernberg, Charlotte, Andersen, Peter, Lindvig, Katrine Prier, Tsochatzis, Emmanuel A, Thiele, Maja, Rinella, Mary E, and Krag, Aleksander

Published
2024
Full Text
View/download PDF

34. Quantification of alcohol intake in patients with steatotic liver disease and excessive alcohol intake

Author

Hansen, Emil Deleuran, Torp, Nikolaj, Johansen, Stine, Hansen, Johanne Kragh, Bergmann, Marianne Lerbæk, Hansen, Camilla Dalby, Detlefsen, Sönke, Andersen, Peter, Villesen, Ida, Bech, Katrine, Thorhauge, Katrine, Jensen, Gitte Hedegaard, Lindvig, Katrine Prier, Hansen, Torben, Tsochatzis, Emmanuel A., Trebicka, Jonel, Thiele, Maja, Krag, Aleksander, and Israelsen, Mads

Published
2024
Full Text
View/download PDF

37. Vorwort

Author

Andersen, Peter, primary and Henkel, Nikolaus, additional

Published
2023
Full Text
View/download PDF

40. How leaders matter : new approaches to understanding the role and effect of UK party leaders in general elections

Author

Andersen, Peter

Subjects
324.241
Abstract

Leaders of political parties are the most well-known and recognisable politicians in the UK. Party leaders dominate political coverage as the face of their party. Due to the level of attention that party leaders receive, voters can quickly evaluate leaders and these evaluations are widely assumed to provide part of the explanation for voter behaviour. Analysis in this thesis furthers the understanding of party leaders by examining leaders in three distinct contexts. I examine: long-term changes in voters' evaluations of leaders from 2014-2017; how significant leader effects were during the 2015 and 2017 general election campaigns; and how the role of leaders has been framed in the analysis of election outcomes presented in election night broadcasts since 1955. This thesis progresses the study of leadership evaluations beyond the consideration of which leadership traits may be the most important, to consider the durability of voters' leadership evaluations over time. I investigate change in leadership evaluations in thirteen waves of the British Election Study (BES) Internet Panel that covers a three-year period. Results suggest that once voters' evaluations of party leaders become established, they remain remarkably stable thereafter. Furthermore, I find that voters distinguish between outgoing and incoming leaders of the same party, advancing arguments that leaders can appeal to voters independently from the party they lead, at least in the short-term. Evidence presented in this thesis also furthers the arguments that voters compare leaders of different parties when forming their evaluations. I investigate leader effects on voter behaviour during the 2015 and 2017 UK general election campaigns. It is well-documented that leaders dominate contemporary campaigns, but it is less clear that leaders can affect vote choice during this period of frantic campaigning. I explore whether changes in leader evaluations during the campaign ultimately affect voters' party choice. Changes to the evaluations of party leaders only have a marginal effect on most voters, as most voters predictably support a party that aligned with their pre-campaign attitudes. However, based on the analysis of pre-campaign attitudes, I identify a sizable group of voters whose vote choice is more strongly affected by changes to leader evaluations. These effects were found to be stronger on this group of voters in 2017, relative to 2015, where leadership evaluations also changed more dramatically over the campaign. While researchers have increasingly recognised leader effects on voter behaviour, I investigate how leaders are used to explain election results in broadcasts and whether this reflects trends in the academic literature. I analyse each BBC election broadcast from 1955-2017, finding party leaders occupy a substantial proportion of discussion in modern programmes. Modern broadcasts of election results seek to explain the election outcome almost instantly after polls have closed and place leaders at the forefront of their coverage. Greater emphasis is placed on the campaign performance of party leaders when interpreting the results and speculation begins about the resignations of losing leaders. Participants in the broadcasts increasingly consider leaders to be responsible for election outcomes, especially when elections are understood to be 'winnable'.

Published
2021
Full Text
View/download PDF

42. Development, validation, and prognostic evaluation of a risk score for long-term liver-related outcomes in the general population: a multicohort study

Author

Alvarez, Marifé, Andersen, Peter, Angeli, Paolo, Ardèvol, Alba, Arslanow, Anita, Beggiato, Luca, Ben Abdesselam, Zahia, Bennett, Lucy, Boutouria, Bajiha, Brocca, Alessandra, Broquetas, M. Teresa, Caballeria, Llorenç, Calvino, Valeria, Camacho, Judith, Capdevila, Aura, Carol, Marta, Castera, Laurent, Cervera, Marta, Cucchietti, Fernando, de Fuentes, Anna, de Knegt, Rob, de Koning, Harry J, Detlefsen, Sonke, Diaz, Alba, Diéguez Bande, José, Esnault, Vanessa, Fabrellas, Núria, Falcó, Josep Lluis, Fernández, Rosa, Fournier, Céline, Fuentes, Matilde, Galle, Peter, García, Edgar, García-Retortillo, Montserrat, Garrido, Esther, Ginès, Pere, Gordillo Medina, Rosa, Gratacós-Ginès, Jordi, Graupera, Isabel, Grgurevic, Ivica, Guha, Indra Neil, Guix, Eva, Hansen, Johanne Kragh, Harris, Rebecca, Hernández Boluda, Elena, Hernández-Ibañez, Rosario, Hoyo, Jordi, Ikram, Arfan, Incicco, Simone, Israelsen, Mads, Juan, Marta, Juanola, Adrià, Kaiser, Ralf, Kamath, Patrick S, Karlsen, Tom H, Kjærgaard, Maria, Korenjak, Marko, Krag, Aleksander, Krawczyk, Marcin, Laboulaye, Philippe, Lambert, Irina, Lammert, Frank, Langkjær Sørensen, Simon, Laserna-Jiménez, Cristina, Lazaro Pi, Sonia, Ledain, Elsa, Levy, Vincent, Lindvig, Katrine Prier, Llorca, Anne, Londoño, Vanessa, Loyer, Guirec, Ma, Ann T., Madir, Anita, Manns, Michael, Marshall, Denise, Martí, M. Lluïsa, Martínez, Sara, Martínez Sala, Ricard, Masa-Font, Roser, Møller Jensen, Jane, Morillas, Rosa M, Muñoz, Laura, Nadal, Ruth, Napoleone, Laura, Navarrete, JM, Newsome, Phillip N, Nielsen, Vibeke, Pérez, Martina, Pericás-Pulido, Juan Manuel, Piano, Salvatore, Pich, Judit, Pose, Elisa, Presas Escobet, Judit, Reichert, Matthias, Riba, Carlota, Roulot, Dominique, Rubio, Ana Belén, Sánchez-Morata, Maria, Schattenberg, Jörn, Serra-Burriel, Miquel, Serra-Burriel, Feliu, Skovborg Just, Louise, Sonneveld, Milan, Soria, Anna, Stern, Christiane, Such, Patricia, Thiele, Maja, Tonon, Marta, Toran, Pere, Torrejón, Antoni, Tsochatzis, Emmanuel A, van Kleef, Laurens, van Wijngaarden, Paulien, Velázquez, Vanessa, Viu, Ana, Weber, Susanne Nicole, Wildsmith, Tracey, Pera, Guillem, Reichert, Mathias, Pericàs, Juan M, Schattenberg, Jörn M, Tsochatztis, Emmanuel A, Garcia-Retortillo, Montserrat, Hernández, Rosario, Expósito, Carmen, Martínez, Alba, Detlefsen, Sönke, Martini, Andrea, Ma, Ann T, Pich, Judith, Bonfill, Eva, Navarrete, J M, Hernáez, Rubén, Allen, Alina, de Knegt, Robert J, and Wong, Vincent Wai-Sun

Published
2023
Full Text
View/download PDF

45. Preparing Quality Teachers

Author

Green, Corinne, Eady, Michelle, and Andersen, Peter

Abstract

There are many factors that impact student learning, with quality educators being one of the most important elements for student success. Accordingly, the promotion of quality teacher preparation programs has become a priority for tertiary institutions, researchers, policymakers, and practitioners. There is a known disparity between tertiary experiences and classroom realities that leave graduate teachers feeling unprepared for the teaching profession. Employing a contextualized learning approach such as situated learning theory in teacher preparation programs can reduce this gap and successfully prepare graduate teachers for the teaching arena. This research project surveyed one cohort (n = 154) at the conclusion of a four-year initial teacher education program, and again six months after graduation, as well as analyzed the subject outlines of the core final year subjects. The study found that the final year of the program incorporated the key tenets of situated learning theory, integrated theory and practice, and prepared the graduates for the realities of the teaching profession by effectively contextualizing their tertiary learning.

Published
2018

49. Using the ELF test, FIB-4 and NAFLD fibrosis score to screen the population for liver disease

Author

Kjaergaard, Maria, Lindvig, Katrine Prier, Thorhauge, Katrine Holtz, Andersen, Peter, Hansen, Johanne Kragh, Kastrup, Nanna, Jensen, Jane Møller, Hansen, Camilla Dalby, Johansen, Stine, Israelsen, Mads, Torp, Nikolaj, Trelle, Morten Beck, Shan, Shan, Detlefsen, Sönke, Antonsen, Steen, Andersen, Jørgen Ellegaard, Graupera, Isabel, Ginés, Pere, Thiele, Maja, and Krag, Aleksander

Published
2023
Full Text
View/download PDF

50. Rifaximin-α for liver fibrosis in patients with alcohol-related liver disease (GALA-RIF): a randomised, double-blind, placebo-controlled, phase 2 trial

Author

Anastasiadou, Ema, Arumugam, Manimozhian, Bork, Peer, Hansen, Torben, Henrar, Roland, Israelsen, Hans, Karsdal, Morten, Legido-Quigley, Cristina, Melberg, Hans Olav, Thiele, Maja, Trebicka, Jonel, Krag, Aleksander, Mann, Mathias, Matthijnssens, Jelle, Israelsen, Mads, Madsen, Bjørn Stæhr, Torp, Nikolaj, Johansen, Stine, Hansen, Camilla Dalby, Detlefsen, Sönke, Andersen, Peter, Hansen, Johanne Kragh, Lindvig, Katrine Prier, Rasmussen, Ditlev Nytoft, Thorhauge, Katrine Holtz, Kjærgaard, Maria, and Arumugam, Manimozhiyan

Published
2023
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results